Publication | Open Access
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
67
Citations
42
References
2021
Year
clinicaltrials.gov; NCT03971799.
| Year | Citations | |
|---|---|---|
Page 1
Page 1